Skip to main content
. 2019 Mar 25;10(3):312–323. doi: 10.1177/2192568219837923

Figure 5.

Figure 5.

VAS baseline scores compared to 24-month follow-up (−3.96 [95% CI: −4.40 to −3.53]; heterogeneity: I2 = 94.7%, P < .001).